244 related articles for article (PubMed ID: 30895904)
1. Performance of SLEDAI-2K to detect a clinically meaningful change in SLE disease activity: a 36-month prospective cohort study of 334 patients.
Jesus D; Rodrigues M; Matos A; Henriques C; Pereira da Silva JA; Inês LS
Lupus; 2019 Apr; 28(5):607-612. PubMed ID: 30895904
[TBL] [Abstract][Full Text] [Related]
2. Derivation and validation of the SLE Disease Activity Score (SLE-DAS): a new SLE continuous measure with high sensitivity for changes in disease activity.
Jesus D; Matos A; Henriques C; Zen M; Larosa M; Iaccarino L; Da Silva JAP; Doria A; Inês LS
Ann Rheum Dis; 2019 Mar; 78(3):365-371. PubMed ID: 30626657
[TBL] [Abstract][Full Text] [Related]
3. Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50 enhances the ability of SLE Responder Index to identify responders in clinical trials.
Touma Z; Gladman DD; Ibañez D; Taghavi-Zadeh S; Urowitz MB
J Rheumatol; 2011 Nov; 38(11):2395-9. PubMed ID: 21885488
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity analyses of four systemic lupus erythematosus disease activity indices in predicting the treatment changes in consecutive visits: a longitudinal study.
Fatemi A; Raeisi A; Sayedbonakdar Z; Smiley A
Clin Rheumatol; 2018 Apr; 37(4):955-962. PubMed ID: 29256112
[TBL] [Abstract][Full Text] [Related]
5. Performance of SLE responder index and lupus low disease activity state in real life: A prospective cohort study.
Ramirez GA; Canti V; Moiola L; Magnoni M; Rovere-Querini P; Coletto LA; Dagna L; Manfredi AA; Bozzolo EP
Int J Rheum Dis; 2019 Sep; 22(9):1752-1761. PubMed ID: 31379114
[TBL] [Abstract][Full Text] [Related]
6. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus.
Uribe AG; Vilá LM; McGwin G; Sanchez ML; Reveille JD; Alarcón GS
J Rheumatol; 2004 Oct; 31(10):1934-40. PubMed ID: 15468356
[TBL] [Abstract][Full Text] [Related]
7. Systemic lupus erythematosus disease activity Index 2000 Responder Index 50: sensitivity to response at 6 and 12 months.
Touma Z; Urowitz MB; Taghavi-Zadeh S; Ibañez D; Gladman DD
Rheumatology (Oxford); 2012 Oct; 51(10):1814-9. PubMed ID: 22718868
[TBL] [Abstract][Full Text] [Related]
8. Correlation between the Modified Systemic Lupus Erythematosus Disease Activity Index 2000 and the European Consensus Lupus Activity Measurement in juvenile systemic lupus erythematosus.
Sato JO; Corrente JE; Saad-Magalhães C
Lupus; 2016 Nov; 25(13):1479-1484. PubMed ID: 27230556
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Responsiveness of British Isles Lupus Assessment Group 2004 Index, Systemic Lupus Erythematosus Disease Activity Index 2000, and British Isles Lupus Assessment Group 2004 Systems Tally.
Yee CS; Gordon C; Isenberg DA; Griffiths B; Teh LS; Bruce IN; Ahmad Y; Rahman A; Prabu A; Akil M; McHugh N; Edwards CJ; D'Cruz D; Khamashta MA; Farewell VT
Arthritis Care Res (Hoboken); 2022 Oct; 74(10):1623-1630. PubMed ID: 33787088
[TBL] [Abstract][Full Text] [Related]
10. The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients.
Yee CS; Farewell VT; Isenberg DA; Griffiths B; Teh LS; Bruce IN; Ahmad Y; Rahman A; Prabu A; Akil M; McHugh N; Edwards C; D'Cruz D; Khamashta MA; Gordon C
Rheumatology (Oxford); 2011 May; 50(5):982-8. PubMed ID: 21245073
[TBL] [Abstract][Full Text] [Related]
11. Associations between physicians' global assessment of disease activity and patient-reported outcomes in patients with systemic lupus erythematosus: A longitudinal study.
Louthrenoo W; Kasitanon N; Morand E; Kandane-Rathnayake R
Lupus; 2021 Sep; 30(10):1586-1595. PubMed ID: 34192957
[TBL] [Abstract][Full Text] [Related]
12. Addition of constitutional symptoms to the SLEDAI-2K improves overall disease activity assessment: A pilot study.
Anderson EW; Sansone M; Shah B; Kline M; Franchin G; Aranow C; Mackay M
Lupus; 2024 Jul; 33(8):840-850. PubMed ID: 38664230
[TBL] [Abstract][Full Text] [Related]
13. Disease activity patterns in a monocentric cohort of SLE patients: a seven-year follow-up study.
Zen M; Bassi N; Nalotto L; Canova M; Bettio S; Gatto M; Ghirardello A; Iaccarino L; Punzi L; Doria A
Clin Exp Rheumatol; 2012; 30(6):856-63. PubMed ID: 22765883
[TBL] [Abstract][Full Text] [Related]
14. Lupus Impact Tracker is responsive to physician and patient assessed changes in systemic lupus erythematosus.
Giangreco D; Devilliers H; Annapureddy N; Block JA; Jolly M
Lupus; 2015 Dec; 24(14):1486-91. PubMed ID: 26162686
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the LFA-REAL clinician-reported outcome (ClinRO) and patient-reported outcome (PRO): data from the Peruvian Almenara Lupus Cohort.
Ugarte-Gil MF; Gamboa-Cardenas RV; Reátegui-Sokolova C; Pimentel-Quiroz VR; Zeña-Huancas P; Elera-Fitzcarrald C; Garcia-Hirsh S; Gil L; Pastor-Asurza CA; Rodriguez-Bellido Z; Merrill J; Askanase AD; Alarcon G; Perich-Campos RA
Lupus Sci Med; 2020 Oct; 7(1):. PubMed ID: 33046557
[TBL] [Abstract][Full Text] [Related]
16. Performance of systemic lupus erythematosus responder index for detecting clinician-rated responders in patients with active systemic lupus erythematosus.
Leosuthamas P; Narongroeknawin P; Chaiamnuay S; Asavatanabodee P; Pakchotanon R
Int J Rheum Dis; 2023 Apr; 26(4):667-672. PubMed ID: 36802112
[TBL] [Abstract][Full Text] [Related]
17. Persistent Disease Activity Remains a Burden for Patients with Systemic Lupus Erythematosus.
Peschken CA; Wang Y; Abrahamowicz M; Pope J; Silverman E; Sayani A; Iczkovitz S; Ross J; Zummer M; Tucker L; Pineau C; Levy D; Hudson M; Hitchon CA; Huber AM; Smith CD; Avina-Zubieta A; Arbillaga H; Chédeville G; Wynant W; Fortin PR;
J Rheumatol; 2019 Feb; 46(2):166-175. PubMed ID: 30219771
[TBL] [Abstract][Full Text] [Related]
18. SLEDAI-2K Does Not Conceal Worsening in a Particular System When There Is Overall Improvement.
Touma Z; Gladman DD; Su J; Ibañez D; Urowitz MB
J Rheumatol; 2015 Aug; 42(8):1401-5. PubMed ID: 26077403
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the Sensitivity to Change of the 36-Item Short Form Health Survey and the Lupus Quality of Life Measure Using Various Definitions of Minimum Clinically Important Differences in Patients With Active Systemic Lupus Erythematosus.
Nantes SG; Strand V; Su J; Touma Z
Arthritis Care Res (Hoboken); 2018 Jan; 70(1):125-133. PubMed ID: 28320078
[TBL] [Abstract][Full Text] [Related]
20. Systemic lupus erythematosus disease activity index 2000 responder index-50: a reliable index for measuring improvement in disease activity.
Touma Z; Urowitz MB; Fortin PR; Landolt C; Toloza SM; Riddell C; Chandran V; Eder L; Ghanem A; Ziouzina O; Taghavi-Zadeh S; Ibañez D; Gladman DD
J Rheumatol; 2011 May; 38(5):868-73. PubMed ID: 21324961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
